OMCM News Three West Coast Pharmaceutical Companie

OMCM News Three West Coast Pharmaceutical Companies Choose OmniComm Systems' TrialMaster Suite to Support Their Clinical Trial Programs

2012-07-25 08:48 ET - News Release

FORT LAUDERDALE, Fla., July 25, 2012 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that its Electronic Data Capture (EDC) suite, TrialMaster®, has been chosen by three West Coast pharmaceutical companies to support multiple clinical trial programs. All of these companies are new to OmniComm and will initially be utilizing TrialMaster to manage the data collection in four clinical trials, including two phase I and two phase II studies.

"We are honored by the number of new customers that have chosen OmniComm to partner with for their clinical research needs," commented Stephen Johnson, OmniComm's President & COO. "This makes 11 new customers for us in the first half of 2012 alone. The word is getting out… better products, better service, better value."

OmniComm is coming off its best year ever in 2011, and continues to show record growth in 2012. OmniComm attributes its success to innovative new products and features, such as TrialMaster's automated SDTM export utility and Dynamic Monitoring module. "TrialMaster has a very flexible architecture that allows us to innovate rapidly," said Keith Howells, SVP of Development. "We are delighted that companies researching the next generation of medicines are seeing the benefits of providing leading edge tools to their staff and investigative sites. Their productivity is our success."